nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—Microtubule Inhibition—Paclitaxel—kidney cancer	0.797	1	CiPCiCtD
Griseofulvin—CYP3A4—Everolimus—kidney cancer	0.0291	0.201	CbGbCtD
Griseofulvin—CYP1A2—Pazopanib—kidney cancer	0.0197	0.136	CbGbCtD
Griseofulvin—CYP3A4—Temsirolimus—kidney cancer	0.0197	0.136	CbGbCtD
Griseofulvin—CYP1A2—Erlotinib—kidney cancer	0.0141	0.0973	CbGbCtD
Griseofulvin—CYP1A2—Sorafenib—kidney cancer	0.0114	0.0791	CbGbCtD
Griseofulvin—CYP3A4—Pazopanib—kidney cancer	0.0103	0.0714	CbGbCtD
Griseofulvin—CYP3A4—Erlotinib—kidney cancer	0.00738	0.051	CbGbCtD
Griseofulvin—CYP3A4—Paclitaxel—kidney cancer	0.00675	0.0466	CbGbCtD
Griseofulvin—CYP3A4—Sorafenib—kidney cancer	0.006	0.0414	CbGbCtD
Griseofulvin—CYP3A4—Vinblastine—kidney cancer	0.00592	0.0409	CbGbCtD
Griseofulvin—CYP3A4—Vincristine—kidney cancer	0.00582	0.0402	CbGbCtD
Griseofulvin—CYP3A4—Sunitinib—kidney cancer	0.00486	0.0336	CbGbCtD
Griseofulvin—CYP3A4—Doxorubicin—kidney cancer	0.00364	0.0251	CbGbCtD
Griseofulvin—Protein urine present—Sorafenib—kidney cancer	0.000579	0.00997	CcSEcCtD
Griseofulvin—Candida infection—Everolimus—kidney cancer	0.000567	0.00977	CcSEcCtD
Griseofulvin—Proteinuria—Sunitinib—kidney cancer	0.000565	0.00972	CcSEcCtD
Griseofulvin—Protein urine present—Sunitinib—kidney cancer	0.000557	0.00959	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Pazopanib—kidney cancer	0.000546	0.0094	CcSEcCtD
Griseofulvin—Neuropathy—Erlotinib—kidney cancer	0.000538	0.00927	CcSEcCtD
Griseofulvin—Oral candidiasis—Paclitaxel—kidney cancer	0.000525	0.00904	CcSEcCtD
Griseofulvin—Neuropathy—Sorafenib—kidney cancer	0.000484	0.00834	CcSEcCtD
Griseofulvin—Candida infection—Sunitinib—kidney cancer	0.000474	0.00816	CcSEcCtD
Griseofulvin—Proteinuria—Gemcitabine—kidney cancer	0.000453	0.0078	CcSEcCtD
Griseofulvin—Protein urine present—Gemcitabine—kidney cancer	0.000447	0.00769	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Gemcitabine—kidney cancer	0.000438	0.00754	CcSEcCtD
Griseofulvin—Oral candidiasis—Capecitabine—kidney cancer	0.000431	0.00741	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Gemcitabine—kidney cancer	0.000421	0.00725	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Erlotinib—kidney cancer	0.000416	0.00716	CcSEcCtD
Griseofulvin—Neuropathy—Vincristine—kidney cancer	0.000394	0.00678	CcSEcCtD
Griseofulvin—Erythema multiforme—Temsirolimus—kidney cancer	0.000379	0.00653	CcSEcCtD
Griseofulvin—Neuropathy—Gemcitabine—kidney cancer	0.000374	0.00644	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Paclitaxel—kidney cancer	0.000367	0.00631	CcSEcCtD
Griseofulvin—Coagulopathy—Capecitabine—kidney cancer	0.000352	0.00605	CcSEcCtD
Griseofulvin—Erythema—Temsirolimus—kidney cancer	0.000349	0.00601	CcSEcCtD
Griseofulvin—Erythema—Pazopanib—kidney cancer	0.000329	0.00566	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vinblastine—kidney cancer	0.000327	0.00563	CcSEcCtD
Griseofulvin—Angioedema—Temsirolimus—kidney cancer	0.000319	0.00549	CcSEcCtD
Griseofulvin—Candida infection—Paclitaxel—kidney cancer	0.000318	0.00548	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Erlotinib—kidney cancer	0.000314	0.00541	CcSEcCtD
Griseofulvin—Neuropathy—Paclitaxel—kidney cancer	0.000313	0.00539	CcSEcCtD
Griseofulvin—Leukopenia—Temsirolimus—kidney cancer	0.000313	0.00538	CcSEcCtD
Griseofulvin—Proteinuria—Capecitabine—kidney cancer	0.000311	0.00536	CcSEcCtD
Griseofulvin—Agranulocytosis—Vinblastine—kidney cancer	0.000311	0.00536	CcSEcCtD
Griseofulvin—Protein urine present—Capecitabine—kidney cancer	0.000307	0.00529	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Capecitabine—kidney cancer	0.000301	0.00518	CcSEcCtD
Griseofulvin—Hepatitis—Everolimus—kidney cancer	0.000298	0.00514	CcSEcCtD
Griseofulvin—Leukopenia—Pazopanib—kidney cancer	0.000295	0.00507	CcSEcCtD
Griseofulvin—Hepatitis—Erlotinib—kidney cancer	0.000288	0.00496	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Sorafenib—kidney cancer	0.000283	0.00487	CcSEcCtD
Griseofulvin—Oral candidiasis—Doxorubicin—kidney cancer	0.000278	0.00478	CcSEcCtD
Griseofulvin—Erythema multiforme—Erlotinib—kidney cancer	0.000272	0.00469	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Sunitinib—kidney cancer	0.000272	0.00468	CcSEcCtD
Griseofulvin—Candida infection—Capecitabine—kidney cancer	0.000261	0.0045	CcSEcCtD
Griseofulvin—Erythema—Everolimus—kidney cancer	0.00026	0.00447	CcSEcCtD
Griseofulvin—Insomnia—Temsirolimus—kidney cancer	0.000258	0.00444	CcSEcCtD
Griseofulvin—Neuropathy—Capecitabine—kidney cancer	0.000257	0.00442	CcSEcCtD
Griseofulvin—Erythema—Erlotinib—kidney cancer	0.000251	0.00431	CcSEcCtD
Griseofulvin—Hepatitis—Sunitinib—kidney cancer	0.000249	0.00429	CcSEcCtD
Griseofulvin—Fatigue—Temsirolimus—kidney cancer	0.000246	0.00423	CcSEcCtD
Griseofulvin—Agranulocytosis—Dactinomycin—kidney cancer	0.000245	0.00422	CcSEcCtD
Griseofulvin—Erythema multiforme—Sorafenib—kidney cancer	0.000245	0.00422	CcSEcCtD
Griseofulvin—Insomnia—Pazopanib—kidney cancer	0.000243	0.00418	CcSEcCtD
Griseofulvin—Paraesthesia—Pazopanib—kidney cancer	0.000241	0.00415	CcSEcCtD
Griseofulvin—Angioedema—Everolimus—kidney cancer	0.000237	0.00409	CcSEcCtD
Griseofulvin—Dyspepsia—Pazopanib—kidney cancer	0.000236	0.00407	CcSEcCtD
Griseofulvin—Hepatitis—Dactinomycin—kidney cancer	0.000236	0.00406	CcSEcCtD
Griseofulvin—Erythema multiforme—Sunitinib—kidney cancer	0.000236	0.00406	CcSEcCtD
Griseofulvin—Leukopenia—Vinblastine—kidney cancer	0.000233	0.00402	CcSEcCtD
Griseofulvin—Leukopenia—Everolimus—kidney cancer	0.000233	0.004	CcSEcCtD
Griseofulvin—Fatigue—Pazopanib—kidney cancer	0.000232	0.00398	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vincristine—kidney cancer	0.00023	0.00396	CcSEcCtD
Griseofulvin—Erythema—Sorafenib—kidney cancer	0.000226	0.00388	CcSEcCtD
Griseofulvin—Erythema multiforme—Dactinomycin—kidney cancer	0.000223	0.00384	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Gemcitabine—kidney cancer	0.000218	0.00376	CcSEcCtD
Griseofulvin—Erythema—Sunitinib—kidney cancer	0.000217	0.00373	CcSEcCtD
Griseofulvin—Hypersensitivity—Temsirolimus—kidney cancer	0.00021	0.00361	CcSEcCtD
Griseofulvin—Agranulocytosis—Gemcitabine—kidney cancer	0.000208	0.00358	CcSEcCtD
Griseofulvin—Angioedema—Sorafenib—kidney cancer	0.000206	0.00355	CcSEcCtD
Griseofulvin—Erythema—Dactinomycin—kidney cancer	0.000205	0.00354	CcSEcCtD
Griseofulvin—Asthenia—Temsirolimus—kidney cancer	0.000205	0.00352	CcSEcCtD
Griseofulvin—Leukopenia—Sorafenib—kidney cancer	0.000202	0.00347	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000199	0.00342	CcSEcCtD
Griseofulvin—Angioedema—Sunitinib—kidney cancer	0.000198	0.00341	CcSEcCtD
Griseofulvin—Diarrhoea—Temsirolimus—kidney cancer	0.000195	0.00336	CcSEcCtD
Griseofulvin—Leukopenia—Sunitinib—kidney cancer	0.000194	0.00334	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—kidney cancer	0.000194	0.00334	CcSEcCtD
Griseofulvin—Asthenia—Pazopanib—kidney cancer	0.000193	0.00332	CcSEcCtD
Griseofulvin—Insomnia—Everolimus—kidney cancer	0.000192	0.0033	CcSEcCtD
Griseofulvin—Paraesthesia—Vinblastine—kidney cancer	0.000191	0.00329	CcSEcCtD
Griseofulvin—Paraesthesia—Everolimus—kidney cancer	0.00019	0.00328	CcSEcCtD
Griseofulvin—Erythema multiforme—Gemcitabine—kidney cancer	0.000189	0.00326	CcSEcCtD
Griseofulvin—Dizziness—Temsirolimus—kidney cancer	0.000188	0.00324	CcSEcCtD
Griseofulvin—Dyspepsia—Everolimus—kidney cancer	0.000187	0.00321	CcSEcCtD
Griseofulvin—Insomnia—Erlotinib—kidney cancer	0.000185	0.00318	CcSEcCtD
Griseofulvin—Leukopenia—Dactinomycin—kidney cancer	0.000184	0.00317	CcSEcCtD
Griseofulvin—Diarrhoea—Pazopanib—kidney cancer	0.000184	0.00316	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000183	0.00315	CcSEcCtD
Griseofulvin—Fatigue—Everolimus—kidney cancer	0.000183	0.00315	CcSEcCtD
Griseofulvin—Vomiting—Temsirolimus—kidney cancer	0.000181	0.00312	CcSEcCtD
Griseofulvin—Dyspepsia—Erlotinib—kidney cancer	0.00018	0.0031	CcSEcCtD
Griseofulvin—Rash—Temsirolimus—kidney cancer	0.00018	0.00309	CcSEcCtD
Griseofulvin—Dermatitis—Temsirolimus—kidney cancer	0.00018	0.00309	CcSEcCtD
Griseofulvin—Headache—Temsirolimus—kidney cancer	0.000179	0.00307	CcSEcCtD
Griseofulvin—Dizziness—Pazopanib—kidney cancer	0.000178	0.00306	CcSEcCtD
Griseofulvin—Fatigue—Erlotinib—kidney cancer	0.000176	0.00304	CcSEcCtD
Griseofulvin—Feeling abnormal—Vinblastine—kidney cancer	0.000175	0.00302	CcSEcCtD
Griseofulvin—Feeling abnormal—Everolimus—kidney cancer	0.000175	0.00301	CcSEcCtD
Griseofulvin—Erythema—Gemcitabine—kidney cancer	0.000174	0.003	CcSEcCtD
Griseofulvin—Vomiting—Pazopanib—kidney cancer	0.000171	0.00294	CcSEcCtD
Griseofulvin—Rash—Pazopanib—kidney cancer	0.000169	0.00291	CcSEcCtD
Griseofulvin—Nausea—Temsirolimus—kidney cancer	0.000169	0.00291	CcSEcCtD
Griseofulvin—Dermatitis—Pazopanib—kidney cancer	0.000169	0.00291	CcSEcCtD
Griseofulvin—Candida infection—Doxorubicin—kidney cancer	0.000168	0.0029	CcSEcCtD
Griseofulvin—Headache—Pazopanib—kidney cancer	0.000168	0.0029	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—kidney cancer	0.000166	0.00285	CcSEcCtD
Griseofulvin—Leukopenia—Vincristine—kidney cancer	0.000164	0.00283	CcSEcCtD
Griseofulvin—Dyspepsia—Sorafenib—kidney cancer	0.000162	0.00279	CcSEcCtD
Griseofulvin—Insomnia—Sunitinib—kidney cancer	0.00016	0.00276	CcSEcCtD
Griseofulvin—Nausea—Pazopanib—kidney cancer	0.00016	0.00275	CcSEcCtD
Griseofulvin—Paraesthesia—Sunitinib—kidney cancer	0.000159	0.00274	CcSEcCtD
Griseofulvin—Fatigue—Sorafenib—kidney cancer	0.000159	0.00273	CcSEcCtD
Griseofulvin—Erythema multiforme—Paclitaxel—kidney cancer	0.000158	0.00273	CcSEcCtD
Griseofulvin—Hypersensitivity—Vinblastine—kidney cancer	0.000157	0.0027	CcSEcCtD
Griseofulvin—Hypersensitivity—Everolimus—kidney cancer	0.000156	0.00269	CcSEcCtD
Griseofulvin—Dyspepsia—Sunitinib—kidney cancer	0.000156	0.00268	CcSEcCtD
Griseofulvin—Leukopenia—Gemcitabine—kidney cancer	0.000156	0.00268	CcSEcCtD
Griseofulvin—Asthenia—Vinblastine—kidney cancer	0.000153	0.00263	CcSEcCtD
Griseofulvin—Fatigue—Sunitinib—kidney cancer	0.000153	0.00263	CcSEcCtD
Griseofulvin—Asthenia—Everolimus—kidney cancer	0.000152	0.00262	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Capecitabine—kidney cancer	0.00015	0.00258	CcSEcCtD
Griseofulvin—Asthenia—Erlotinib—kidney cancer	0.000147	0.00253	CcSEcCtD
Griseofulvin—Urticaria—Sorafenib—kidney cancer	0.000146	0.00252	CcSEcCtD
Griseofulvin—Erythema—Paclitaxel—kidney cancer	0.000146	0.00251	CcSEcCtD
Griseofulvin—Diarrhoea—Vinblastine—kidney cancer	0.000146	0.00251	CcSEcCtD
Griseofulvin—Diarrhoea—Everolimus—kidney cancer	0.000145	0.0025	CcSEcCtD
Griseofulvin—Fatigue—Dactinomycin—kidney cancer	0.000145	0.00249	CcSEcCtD
Griseofulvin—Agranulocytosis—Capecitabine—kidney cancer	0.000143	0.00246	CcSEcCtD
Griseofulvin—Dizziness—Vinblastine—kidney cancer	0.000141	0.00242	CcSEcCtD
Griseofulvin—Dizziness—Everolimus—kidney cancer	0.00014	0.00241	CcSEcCtD
Griseofulvin—Diarrhoea—Erlotinib—kidney cancer	0.00014	0.00241	CcSEcCtD
Griseofulvin—Feeling abnormal—Dactinomycin—kidney cancer	0.000138	0.00238	CcSEcCtD
Griseofulvin—Hepatitis—Capecitabine—kidney cancer	0.000137	0.00237	CcSEcCtD
Griseofulvin—Hypersensitivity—Sorafenib—kidney cancer	0.000136	0.00233	CcSEcCtD
Griseofulvin—Insomnia—Vincristine—kidney cancer	0.000135	0.00233	CcSEcCtD
Griseofulvin—Vomiting—Vinblastine—kidney cancer	0.000135	0.00233	CcSEcCtD
Griseofulvin—Dizziness—Erlotinib—kidney cancer	0.000135	0.00233	CcSEcCtD
Griseofulvin—Vomiting—Everolimus—kidney cancer	0.000135	0.00232	CcSEcCtD
Griseofulvin—Paraesthesia—Vincristine—kidney cancer	0.000135	0.00232	CcSEcCtD
Griseofulvin—Rash—Everolimus—kidney cancer	0.000134	0.0023	CcSEcCtD
Griseofulvin—Dermatitis—Everolimus—kidney cancer	0.000134	0.0023	CcSEcCtD
Griseofulvin—Headache—Vinblastine—kidney cancer	0.000133	0.0023	CcSEcCtD
Griseofulvin—Angioedema—Paclitaxel—kidney cancer	0.000133	0.00229	CcSEcCtD
Griseofulvin—Headache—Everolimus—kidney cancer	0.000133	0.00229	CcSEcCtD
Griseofulvin—Asthenia—Sorafenib—kidney cancer	0.000132	0.00227	CcSEcCtD
Griseofulvin—Leukopenia—Paclitaxel—kidney cancer	0.00013	0.00225	CcSEcCtD
Griseofulvin—Hypersensitivity—Sunitinib—kidney cancer	0.00013	0.00225	CcSEcCtD
Griseofulvin—Vomiting—Erlotinib—kidney cancer	0.00013	0.00224	CcSEcCtD
Griseofulvin—Erythema multiforme—Capecitabine—kidney cancer	0.00013	0.00224	CcSEcCtD
Griseofulvin—Fatigue—Vincristine—kidney cancer	0.000129	0.00222	CcSEcCtD
Griseofulvin—Rash—Erlotinib—kidney cancer	0.000129	0.00222	CcSEcCtD
Griseofulvin—Dermatitis—Erlotinib—kidney cancer	0.000129	0.00222	CcSEcCtD
Griseofulvin—Insomnia—Gemcitabine—kidney cancer	0.000129	0.00221	CcSEcCtD
Griseofulvin—Headache—Erlotinib—kidney cancer	0.000128	0.00221	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000128	0.0022	CcSEcCtD
Griseofulvin—Paraesthesia—Gemcitabine—kidney cancer	0.000128	0.0022	CcSEcCtD
Griseofulvin—Asthenia—Sunitinib—kidney cancer	0.000127	0.00219	CcSEcCtD
Griseofulvin—Nausea—Vinblastine—kidney cancer	0.000126	0.00218	CcSEcCtD
Griseofulvin—Nausea—Everolimus—kidney cancer	0.000126	0.00217	CcSEcCtD
Griseofulvin—Diarrhoea—Sorafenib—kidney cancer	0.000126	0.00217	CcSEcCtD
Griseofulvin—Hypersensitivity—Dactinomycin—kidney cancer	0.000124	0.00213	CcSEcCtD
Griseofulvin—Fatigue—Gemcitabine—kidney cancer	0.000123	0.00211	CcSEcCtD
Griseofulvin—Dizziness—Sorafenib—kidney cancer	0.000122	0.00209	CcSEcCtD
Griseofulvin—Nausea—Erlotinib—kidney cancer	0.000122	0.00209	CcSEcCtD
Griseofulvin—Diarrhoea—Sunitinib—kidney cancer	0.000121	0.00209	CcSEcCtD
Griseofulvin—Asthenia—Dactinomycin—kidney cancer	0.00012	0.00207	CcSEcCtD
Griseofulvin—Confusional state—Paclitaxel—kidney cancer	0.00012	0.00206	CcSEcCtD
Griseofulvin—Erythema—Capecitabine—kidney cancer	0.00012	0.00206	CcSEcCtD
Griseofulvin—Dizziness—Sunitinib—kidney cancer	0.000117	0.00202	CcSEcCtD
Griseofulvin—Feeling abnormal—Gemcitabine—kidney cancer	0.000117	0.00202	CcSEcCtD
Griseofulvin—Vomiting—Sorafenib—kidney cancer	0.000117	0.00201	CcSEcCtD
Griseofulvin—Rash—Sorafenib—kidney cancer	0.000116	0.002	CcSEcCtD
Griseofulvin—Dermatitis—Sorafenib—kidney cancer	0.000116	0.002	CcSEcCtD
Griseofulvin—Headache—Sorafenib—kidney cancer	0.000115	0.00198	CcSEcCtD
Griseofulvin—Diarrhoea—Dactinomycin—kidney cancer	0.000115	0.00197	CcSEcCtD
Griseofulvin—Vomiting—Sunitinib—kidney cancer	0.000113	0.00194	CcSEcCtD
Griseofulvin—Rash—Sunitinib—kidney cancer	0.000112	0.00192	CcSEcCtD
Griseofulvin—Dermatitis—Sunitinib—kidney cancer	0.000112	0.00192	CcSEcCtD
Griseofulvin—Headache—Sunitinib—kidney cancer	0.000111	0.00191	CcSEcCtD
Griseofulvin—Hypersensitivity—Vincristine—kidney cancer	0.00011	0.0019	CcSEcCtD
Griseofulvin—Nausea—Sorafenib—kidney cancer	0.000109	0.00188	CcSEcCtD
Griseofulvin—Insomnia—Paclitaxel—kidney cancer	0.000108	0.00185	CcSEcCtD
Griseofulvin—Asthenia—Vincristine—kidney cancer	0.000107	0.00185	CcSEcCtD
Griseofulvin—Leukopenia—Capecitabine—kidney cancer	0.000107	0.00184	CcSEcCtD
Griseofulvin—Paraesthesia—Paclitaxel—kidney cancer	0.000107	0.00184	CcSEcCtD
Griseofulvin—Vomiting—Dactinomycin—kidney cancer	0.000107	0.00183	CcSEcCtD
Griseofulvin—Rash—Dactinomycin—kidney cancer	0.000106	0.00182	CcSEcCtD
Griseofulvin—Nausea—Sunitinib—kidney cancer	0.000105	0.00181	CcSEcCtD
Griseofulvin—Dyspepsia—Paclitaxel—kidney cancer	0.000105	0.0018	CcSEcCtD
Griseofulvin—Fatigue—Paclitaxel—kidney cancer	0.000103	0.00177	CcSEcCtD
Griseofulvin—Diarrhoea—Vincristine—kidney cancer	0.000102	0.00176	CcSEcCtD
Griseofulvin—Asthenia—Gemcitabine—kidney cancer	0.000102	0.00175	CcSEcCtD
Griseofulvin—Nausea—Dactinomycin—kidney cancer	9.96e-05	0.00171	CcSEcCtD
Griseofulvin—Dizziness—Vincristine—kidney cancer	9.91e-05	0.0017	CcSEcCtD
Griseofulvin—Confusional state—Capecitabine—kidney cancer	9.85e-05	0.00169	CcSEcCtD
Griseofulvin—Feeling abnormal—Paclitaxel—kidney cancer	9.8e-05	0.00169	CcSEcCtD
Griseofulvin—Diarrhoea—Gemcitabine—kidney cancer	9.72e-05	0.00167	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Doxorubicin—kidney cancer	9.67e-05	0.00166	CcSEcCtD
Griseofulvin—Vomiting—Vincristine—kidney cancer	9.52e-05	0.00164	CcSEcCtD
Griseofulvin—Urticaria—Paclitaxel—kidney cancer	9.45e-05	0.00163	CcSEcCtD
Griseofulvin—Rash—Vincristine—kidney cancer	9.45e-05	0.00163	CcSEcCtD
Griseofulvin—Dermatitis—Vincristine—kidney cancer	9.44e-05	0.00162	CcSEcCtD
Griseofulvin—Headache—Vincristine—kidney cancer	9.38e-05	0.00162	CcSEcCtD
Griseofulvin—Agranulocytosis—Doxorubicin—kidney cancer	9.21e-05	0.00159	CcSEcCtD
Griseofulvin—Vomiting—Gemcitabine—kidney cancer	9.04e-05	0.00156	CcSEcCtD
Griseofulvin—Rash—Gemcitabine—kidney cancer	8.96e-05	0.00154	CcSEcCtD
Griseofulvin—Dermatitis—Gemcitabine—kidney cancer	8.95e-05	0.00154	CcSEcCtD
Griseofulvin—Headache—Gemcitabine—kidney cancer	8.9e-05	0.00153	CcSEcCtD
Griseofulvin—Nausea—Vincristine—kidney cancer	8.9e-05	0.00153	CcSEcCtD
Griseofulvin—Hepatitis—Doxorubicin—kidney cancer	8.86e-05	0.00152	CcSEcCtD
Griseofulvin—Insomnia—Capecitabine—kidney cancer	8.83e-05	0.00152	CcSEcCtD
Griseofulvin—Paraesthesia—Capecitabine—kidney cancer	8.77e-05	0.00151	CcSEcCtD
Griseofulvin—Hypersensitivity—Paclitaxel—kidney cancer	8.77e-05	0.00151	CcSEcCtD
Griseofulvin—Dyspepsia—Capecitabine—kidney cancer	8.59e-05	0.00148	CcSEcCtD
Griseofulvin—Asthenia—Paclitaxel—kidney cancer	8.54e-05	0.00147	CcSEcCtD
Griseofulvin—Nausea—Gemcitabine—kidney cancer	8.44e-05	0.00145	CcSEcCtD
Griseofulvin—Fatigue—Capecitabine—kidney cancer	8.42e-05	0.00145	CcSEcCtD
Griseofulvin—Erythema multiforme—Doxorubicin—kidney cancer	8.38e-05	0.00144	CcSEcCtD
Griseofulvin—Diarrhoea—Paclitaxel—kidney cancer	8.14e-05	0.0014	CcSEcCtD
Griseofulvin—Feeling abnormal—Capecitabine—kidney cancer	8.05e-05	0.00138	CcSEcCtD
Griseofulvin—Dizziness—Paclitaxel—kidney cancer	7.87e-05	0.00135	CcSEcCtD
Griseofulvin—Urticaria—Capecitabine—kidney cancer	7.76e-05	0.00134	CcSEcCtD
Griseofulvin—Erythema—Doxorubicin—kidney cancer	7.71e-05	0.00133	CcSEcCtD
Griseofulvin—Vomiting—Paclitaxel—kidney cancer	7.56e-05	0.0013	CcSEcCtD
Griseofulvin—Rash—Paclitaxel—kidney cancer	7.5e-05	0.00129	CcSEcCtD
Griseofulvin—Dermatitis—Paclitaxel—kidney cancer	7.49e-05	0.00129	CcSEcCtD
Griseofulvin—Headache—Paclitaxel—kidney cancer	7.45e-05	0.00128	CcSEcCtD
Griseofulvin—Hypersensitivity—Capecitabine—kidney cancer	7.19e-05	0.00124	CcSEcCtD
Griseofulvin—Nausea—Paclitaxel—kidney cancer	7.07e-05	0.00122	CcSEcCtD
Griseofulvin—Asthenia—Capecitabine—kidney cancer	7.01e-05	0.00121	CcSEcCtD
Griseofulvin—Leukopenia—Doxorubicin—kidney cancer	6.9e-05	0.00119	CcSEcCtD
Griseofulvin—Diarrhoea—Capecitabine—kidney cancer	6.68e-05	0.00115	CcSEcCtD
Griseofulvin—Dizziness—Capecitabine—kidney cancer	6.46e-05	0.00111	CcSEcCtD
Griseofulvin—Confusional state—Doxorubicin—kidney cancer	6.35e-05	0.00109	CcSEcCtD
Griseofulvin—Vomiting—Capecitabine—kidney cancer	6.21e-05	0.00107	CcSEcCtD
Griseofulvin—Rash—Capecitabine—kidney cancer	6.16e-05	0.00106	CcSEcCtD
Griseofulvin—Dermatitis—Capecitabine—kidney cancer	6.15e-05	0.00106	CcSEcCtD
Griseofulvin—Headache—Capecitabine—kidney cancer	6.12e-05	0.00105	CcSEcCtD
Griseofulvin—Nausea—Capecitabine—kidney cancer	5.8e-05	0.000998	CcSEcCtD
Griseofulvin—Insomnia—Doxorubicin—kidney cancer	5.69e-05	0.00098	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—kidney cancer	5.65e-05	0.000973	CcSEcCtD
Griseofulvin—Dyspepsia—Doxorubicin—kidney cancer	5.54e-05	0.000954	CcSEcCtD
Griseofulvin—Fatigue—Doxorubicin—kidney cancer	5.43e-05	0.000934	CcSEcCtD
Griseofulvin—Feeling abnormal—Doxorubicin—kidney cancer	5.19e-05	0.000893	CcSEcCtD
Griseofulvin—Urticaria—Doxorubicin—kidney cancer	5e-05	0.000861	CcSEcCtD
Griseofulvin—Hypersensitivity—Doxorubicin—kidney cancer	4.64e-05	0.000798	CcSEcCtD
Griseofulvin—Asthenia—Doxorubicin—kidney cancer	4.52e-05	0.000777	CcSEcCtD
Griseofulvin—Diarrhoea—Doxorubicin—kidney cancer	4.31e-05	0.000741	CcSEcCtD
Griseofulvin—Dizziness—Doxorubicin—kidney cancer	4.16e-05	0.000716	CcSEcCtD
Griseofulvin—Vomiting—Doxorubicin—kidney cancer	4e-05	0.000689	CcSEcCtD
Griseofulvin—Rash—Doxorubicin—kidney cancer	3.97e-05	0.000683	CcSEcCtD
Griseofulvin—Dermatitis—Doxorubicin—kidney cancer	3.96e-05	0.000682	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—kidney cancer	3.94e-05	0.000679	CcSEcCtD
Griseofulvin—Nausea—Doxorubicin—kidney cancer	3.74e-05	0.000643	CcSEcCtD
